GlassScriptPhysician profile
Cory Heal
NPI 1366970337
$11,221.54
in general payments reported to CMS, 2019-2025
65 companies · $4,534 in 2025
The $4,534 reported for 2025 was more than what 94% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $15.09 · 2021: $161 · 2022: $966 · 2023: $1,409 · 2024: $3,948 · 2025: $4,534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,133 · Travel and Lodging: $678 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,132.70 |
| Travel and Lodging | $677.75 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,179.04 | 2024-2025 | Barrigel |
| Novartis Pharmaceuticals Corporation | $872.90 | 2022-2025 | |
| Novocure INC. | $824.52 | 2019-2025 | Optune, Optune Gio, Optune Lua (Novottf-200t) |
| Astrazeneca Pharmaceuticals LP | $652.16 | 2022-2025 | Imfinzi, Enhertu, Lynparza |
| Pfizer INC. | $583.36 | 2022-2025 | |
| Janssen Biotech, INC. | $565.67 | 2019-2025 | Darzalex, Tecvayli, Talvey |
| Daiichi Sankyo INC. | $515.39 | 2023-2025 | Enhertu, Vanflyta, Injectafer |
| Progenics Pharmaceuticals, INC. | $483.53 | 2022-2025 | Pylarify |
| Tactile Systems Technology INC | $432.51 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Merck Sharp & Dohme LLC | $360.55 | 2023-2025 | Keytruda, Lynparza, Welireg |
| Abbvie INC. | $353.62 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $326.31 | 2022-2025 | Alunbrig, Fruzaqla, Ninlaro |
| Visionrt, INC. | $283.96 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $261.05 | 2023-2025 | Orgovyx |
| Seagen INC. | $252.12 | 2022-2023 | Tukysa, Padcev |
Show all 65 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cory Heal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.